CENTREXION THERAPEUTICS
Live / Registered — Registered (as of 18 Jan 2022)
What this means for you
Registered since 18 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87684482
- Registration number
- 6622788
- Mark type
- Stylized text
- Filed
- 14 Nov 2017
- Published for opposition
- 09 Oct 2018
- Registered
- 18 Jan 2022
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use by humans in the fields of pain relief, prevention, management, and treatment
Owner
- Centrexion Therapeutics Corporation, Boston, MA, US
- Centrexion Therapeutics Corporation, Boston, MA, US
- Centrexion Therapeutics Corporation, Boston, MA, US
Prosecution history
- 11 Mar 2026 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 18 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Dec 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Dec 2021 — USE AMENDMENT FILED
- 03 Dec 2021 — TEAS STATEMENT OF USE RECEIVED
- 11 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jun 2021 — SOU EXTENSION 5 GRANTED
- 04 Jun 2021 — SOU EXTENSION 5 FILED
- 10 Jun 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 04 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2020 — SOU EXTENSION 4 GRANTED
- 02 Dec 2020 — SOU EXTENSION 4 FILED